CompoAtlas

OMBRELLE SPF 50+ UVA+UVB

Natural health product licensed in Canada

Licence holder
OMBRELLE CANADA
NPN or DIN-HM
80080409
Status
Inactive licence
Licence date
3 October 2017
Revision date
Not provided
Form
Lotion
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Dioxyde de titane

Source : Dioxyde de titane

14.9 Pour cent

Non-medicinal ingredients

Hectorite de distéardimonium, Aqua, Acide stéarique, Caprylyl méthicone, Ether dicaprylylique, dl-alpha tocophérol, Benzoate d'alkyle en C12 à 15, Polymère croisé de diméthicone/PEG-10/15, Alumine, Pentylène glycol, Carbonate de propylène, Carbonate de dicaprylyle, PEG-9 Polydiméthylsiloxy éthyl diméthicone, Phénoxyéthanol, Isohexadécane, Copolymères d'acrylates/de styrènes, Citrate de sodium, Talc, Caprylyl glycol, Triéthylhexanoine, Isododécane, Hydroxyde d'aluminium, Diméthicone, Acide poly(hydroxystéarique), Stéarate d'aluminium, Sulfate de magnésium, Dipropylène glycol, Laurate de PEG-8

PopulationAgeQuantity per servingFrequency
Sous-population S/ONot specified1 Lotion1 Tous les jours

Uses authorised in Canada

SPF 50+.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80080409

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line